Colchicine
43 NDCs across 19 manufacturers|38 Generic,5 Brand
Colchicine is used to treat amyloidosis, familial mediterranean fever, gout and biliary liver cirrhosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 29, 2009, and the first generic was approved Sep 28, 2016. FDA's Orange Book lists 18 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $90 million on Colchicine across 1.5 million claims for 649,000 beneficiaries.
Colchicine is available as 43 NDCs from 19 manufacturers (38 generic, 5 brand), with NADAC prices from $0.12 to $6.91 per EA — the most expensive product costs about 57× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
43
38G / 5B
Manufacturers
19
competing in market
Price Spread
$0.12 – $6.91
per EA
7d Activity
avg -0.1% WoW · of 43 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Camber Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Alkaloid class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
19 manufacturers producing COLCHICINE(2 pricing outliers)
Frequently Asked Questions
What is Colchicine used to treat?
Colchicine is used to treat amyloidosis, familial mediterranean fever, gout and biliary liver cirrhosis, per the National Library of Medicine's MED-RT classification.
When did Colchicine become available as a generic?
FDA approved the first generic Colchicine (ANDA) on Sep 28, 2016. The Orange Book currently lists 18 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Colchicine?
In 2024, Medicare Part D spent $90 million on Colchicine across 1.5 million claims for 649,000 beneficiaries.
How many Colchicine products are on the market?
The Colchicine drug market contains 43 NDCs from 19 manufacturers — 38 generic and 5 brand products.
What is the price range for Colchicine?
NADAC reference prices for Colchicine range from $0.1221 to $6.9085 per EA — the most expensive product costs about 57× the cheapest.
Is generic Colchicine cheaper than brand?
The average generic NADAC for Colchicine is $0.6395 per EA, versus $6.3810 for brand-labeled products — brand versions average about 10.0× the generic price.
Which manufacturers make Colchicine?
19 manufacturers list Colchicine in NADAC. Ranked by number of NDCs, the largest are Camber Pharmaceuticals Inc. (4), Aurobindo Pharma Limited (4), Hikma Specialty USA Inc. (3), Hikma Pharmaceuticals USA Inc. (3), Endo USA Inc. (3).
How has the price of Colchicine changed recently?
Over the past 7 days, 26 Colchicine NDCs rose and 12 fell, with a market-wide average change of -0.1%.